BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14961915)

  • 1. Granular cell basal cell carcinoma.
    Dundr P; Stork J; Povýsil C; Vosmík F
    Australas J Dermatol; 2004 Feb; 45(1):70-2. PubMed ID: 14961915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granular cell basal cell carcinoma: A case report.
    Ma X; Wang G; Kuwadekar A; Zhao M; Hu W; Wu Y; Yi Z; Xu X; Xu L
    J Cutan Pathol; 2018 Mar; 45(3):223-225. PubMed ID: 29193208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ber-EP4 and MNF-116 in a previously undescribed morphologic pattern of granular basal cell carcinoma.
    Hayden AA; Shamma HN
    Am J Dermatopathol; 2001 Dec; 23(6):530-2. PubMed ID: 11801795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granular cell basal cell carcinoma: report of a case and review of the literature.
    Claassen SL; Royer MC; Rush WL
    Am J Dermatopathol; 2014 Jul; 36(7):e121-4. PubMed ID: 24247582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermal non-neural granular cell tumour (so-called primitive polypoid granular cell tumour): a distinctive entity further delineated in a clinicopathological study of 11 cases.
    Chaudhry IH; Calonje E
    Histopathology; 2005 Aug; 47(2):179-85. PubMed ID: 16045779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody Ber EP4 distinguishes basal-cell carcinoma from squamous-cell carcinoma of the skin.
    Tellechea O; Reis JP; Domingues JC; Baptista AP
    Am J Dermatopathol; 1993 Oct; 15(5):452-5. PubMed ID: 8238781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pan-cytokeratin markers for rapid frozen section immunocytochemistry from head and facial Mohs cases of basal cell carcinoma: a comparison and evaluation to determine the marker of choice.
    Orchard GE; Wojcik K; Shams F; Georgaki E; Quaye CJ; Fernando P; Torres J; Ismail F; Shams M
    Br J Biomed Sci; 2015; 72(2):61-6. PubMed ID: 26126321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple lesions of granular cell basal cell carcinoma: a case report.
    Jedrych J; Busam KJ
    J Cutan Pathol; 2014 Jan; 41(1):45-50. PubMed ID: 24152299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD68 and factor XIIIa expressions in granular-cell tumor of the skin.
    Nikkels AF; Arrese Estrada J; Piérard-Franchimont C; Piérard GE
    Dermatology; 1993; 186(2):106-8. PubMed ID: 8094017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granular cell basal cell carcinoma. Light microscopy, immunohistochemical and ultrastructural study.
    García Prats MD; López Carreira M; Martínez-González MA; Ballestín C; Gil R; De Prada I
    Virchows Arch A Pathol Anat Histopathol; 1993; 422(2):173-7. PubMed ID: 7682021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microcystic adnexal carcinoma: an immunohistochemical study including markers of proliferation and apoptosis.
    Smith KJ; Williams J; Corbett D; Skelton H
    Am J Surg Pathol; 2001 Apr; 25(4):464-71. PubMed ID: 11257620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal cell carcinomas are populated by melanocytes and Langerhans [correction of Langerhan's] cells.
    Florell SR; Zone JJ; Gerwels JW
    Am J Dermatopathol; 2001 Feb; 23(1):24-8. PubMed ID: 11176048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granular cell tumor mimicking a squamous cell carcinoma of the tongue: a case report.
    Ferreira JC; Oton-Leite AF; Guidi R; Mendonça EF
    BMC Res Notes; 2017 Jan; 10(1):14. PubMed ID: 28057062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ber-EP4 is a useful marker for follicular germinative cell differentiation of cutaneous epithelial neoplasms.
    Ansai S; Takayama R; Kimura T; Kawana S
    J Dermatol; 2012 Aug; 39(8):688-92. PubMed ID: 22300237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristic Ber-EP4 and EMA expression in sebaceoma is immunohistochemically distinct from basal cell carcinoma.
    Fan YS; Carr RA; Sanders DS; Smith AP; Lazar AJ; Calonje E
    Histopathology; 2007 Jul; 51(1):80-6. PubMed ID: 17593083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ber EP4 and epithelial membrane antigen aid distinction of basal cell, squamous cell and basosquamous carcinomas of the skin.
    Beer TW; Shepherd P; Theaker JM
    Histopathology; 2000 Sep; 37(3):218-23. PubMed ID: 10971697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ber-EP4-positive phenotype differentiates actinic keratosis from superficial basal cell carcinoma.
    Tope WD; Nowfar-Rad M; Kist DA
    Dermatol Surg; 2000 May; 26(5):415-8. PubMed ID: 10816226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical demonstration of D2-40 in basal cell carcinomas of the skin.
    Ishida M; Kushima R; Okabe H
    J Cutan Pathol; 2008 Oct; 35(10):926-30. PubMed ID: 18537863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistologic differential diagnosis of basal cell carcinoma, squamous cell carcinoma, and trichoepithelioma in small cutaneous biopsy specimens.
    Swanson PE; Fitzpatrick MM; Ritter JH; Glusac EJ; Wick MR
    J Cutan Pathol; 1998 Mar; 25(3):153-9. PubMed ID: 9550314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A collision tumor involving Basal cell carcinoma and lentigo maligna melanoma.
    Belisle A; Gautier MS; Ghozali F; Plantier F; Wechsler J
    Am J Dermatopathol; 2005 Aug; 27(4):319-21. PubMed ID: 16121053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.